Felicia Vonella

Vice President, Investor Relations, Acorda Therapeutics, Inc.

Felicia is the IRO for Acorda Therapeutics, a publicly-traded biotech company based in NY. She has been the IRO of Acorda since 2013 and is responsible for IR and corporate communications. Prior to Acorda, Felicia had a communications consultancy for 12 years focusing on life sciences companies, managing full-service IR programs as well as transaction-oriented assignments.
 
Felicia started her IR career at Dewe Rogerson Inc., holding various IR positions. In 1994, Felicia was named Director of Latin America and was responsible for growing that region. Prior to Dewe Rogerson’s acquisition by Citigate, Felicia was responsible for the worldwide investor relations business. After leaving Dewe Rogerson in 1998, Felicia moved to London to develop the IR function within Imagination, a large marketing and digital media company. Upon her return to the U.S., she joined TheStreet.com as Senior Vice President of Investor Relations.
 
Felicia is a current NIRI New York board member.